Live feed06:45:00·93dPRReleasevia QuantisnowPfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR TrialByQuantisnow·Wall Street's wire, on your screen.PFE· Pfizer Inc.VALN· Valneva SEHealth Care
